Peroxisome proliferator-activated receptor is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis
- 1 April 2000
- journal article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 21 (4) , 823-826
- https://doi.org/10.1093/carcin/21.4.823
Abstract
Peroxisome proliferators increase hepatocyte proliferation and cause liver tumors in rodents, yet the mechanism of action is not understood. Based on studies with null mice it is known that peroxisome proliferator-activated receptor-α (PPARα) is involved. There is also evidence that Kupffer cells play a central role in peroxisome proliferator-induced carcinogenesis, most likely via mechanisms involving increases in superoxide, activation of nuclear factor κB and production of tumor necrosis factor-α (TNFα). However, it is not known whether PPARα is constitutively expressed in Kupffer cells. Therefore, the expression of PPAR isoforms in rat Kupffer and parenchymal cells was examined. Kupffer cells and hepatocytes of >99% purity were isolated from rats fed either a control diet or one containing 0.1% WY-14,643 for 1 week. Protein and RNA were obtained and PPAR expression was analyzed using northern and western blots. PPARα, PPARβ and PPARγ mRNA was detected in purified hepatocytes. In Kupffer cells, mRNA encoding PPARγ was present while transcripts for PPARα and PPARβ were not detected. Immunoblots were consistent with the results found by northern analysis. Moreover, when Kupffer cells from wild-type or PPARα-null mice were treated with WY-14,643 in vitro, superoxide production was similar. Combined, these results show that PPARα is expressed in rat parenchymal cells but not in Kupffer cells. These data are consistent with the hypothesis that parenchymal cells respond to Kupffer cell-derived TNFα via mechanisms dependent on PPARα within the parenchymal cells.Keywords
This publication has 19 references indexed in Scilit:
- ROLE OF KUPFFER CELLS IN PEROXISOME PROLIFERATOR-INDUCED HEPATOCYTE PROLIFERATION*Drug Metabolism Reviews, 1999
- Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated ReceptorJNCI Journal of the National Cancer Institute, 1998
- Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liverCarcinogenesis: Integrative Cancer Research, 1998
- Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643Carcinogenesis: Integrative Cancer Research, 1997
- Dietary Glycine Prevents Increases in Hepatocyte Proliferation Caused by the Peroxisome Proliferator WY-14,643Chemical Research in Toxicology, 1997
- Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferatorsCarcinogenesis: Integrative Cancer Research, 1997
- Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin.The Journal of cell biology, 1994
- Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liverCarcinogenesis: Integrative Cancer Research, 1990
- DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.Proceedings of the National Academy of Sciences, 1984
- A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.Proceedings of the National Academy of Sciences, 1976